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Infants have been shown to have compromised lung func-
tion after cardiac operations.1 However, little is known about
the specific effects of cardiopulmonary bypass (CPB) on the
metabolism of endogenous pulmonary surfactant in infants
undergoing an operation for congenital heart disease. The
purpose of this study was to determine whether an alteration
in endogenous pulmonary surfactant is, in part, responsible
for the postoperative change in lung function observed in
infants undergoing CPB during an operation for congenital
heart disease.
Methods 
Patient population. The study was approved by the
Institutional Review Board at St Christopher’s Hospital for
Children and informed written consent was obtained.
Fourteen infants with congenital heart disease undergoing
both palliative and corrective procedures were enrolled in the
study. The patients were divided according to the procedure
performed: those infants undergoing cardiac procedures that
required CPB (CPB group; n = 9) and those infants undergo-
ing cardiac procedures that did not require CPB (no CPB
group; n = 5).
Operative care. Infants had standard monitoring of electro-
cardiogram, in-line blood presssure, transcutaneous oxyhe-
moglobin saturation, and end-tidal carbon dioxide concentra-
tion throughout the procedure. Anesthesia was induced with
halothane then converted to a fentanyl technique.
Extracorporeal circulation was performed with a membrane
oxygenator (Cobe-VPC, Lakewood, Colo). Once full flow
was achieved on CPB, mechanical ventilation was terminat-
ed, and infants were maintained on endotracheal continuous
positive airway pressure. Infants in the no CPB group
received volume-limited, time-cycled ventilation throughout
the procedures. Two patients in the CPB group underwent
deep hypothermic circulatory arrest.
Pulmonary mechanics measurements. Dynamic pulmonary
mechanics were determined by pneumotachometry and air-
way manometery (PeDS; MAS Inc, Hatfield, Pa). Sampling
of pressure and flow signal occurred over a 30- to 60-second
period. Signals for pressure, air flow, and volume were used
to determine compliance of the respiratory system (CRS; mil-
liliter · centimeter H2O–1 · kilogram–1) by least mean square
analysis. Preoperative pulmonary function analysis was
obtained in the operating room shortly after endotracheal
intubation and the induction of anesthesia. Postoperative pul-
monary function analysis was performed in the operating
room or cardiac care unit within 1 hour after the completion
of the operative procedure.
Tracheal aspirates. Tracheal lavage coincident with preop-
erative pulmonary function evaluation was performed in the
operating room. Similarly, postoperative specimens were
obtained in the operating room or cardiac care unit within 1
hour of completion of the operative procedure, immediately
before the postoperative pulmonary function analysis. Lavage
specimens were obtained by instilling 4 mL of saline solution
into the endotracheal tube. The distal trachea was then suc-
tioned into an in-line suction trap (Sherwood Medical, St
Louis, Mo). 
Protein and phospholipid determination. Total protein was
measured by a modified Lowry method. To determine phos-
pholipid concentration, aliquots of the lavage fluid were
extracted with chloroform:methanol and analyzed for lipid
phosphorus.
Data analysis. Parametric and nonparametric differences
between each group were evaluated by the Student t test or
c
2
. All data are expressed as the mean ± SD.
Results. All infants tolerated the procedure for tracheal
lavage and pulmonary function testing without difficulty. The
differences between the groups in age, gestational age,
weight, and gender were no more than expected by chance
(Table I). Infants in the CPB group remained on CPB for 84
± 18.9 minutes.
CRS did not differ significantly before the operation
between the 2 groups. However, CRS exhibited a decline
from before to after the operation in those infants who
required CPB as part of the operative procedure. There was
no change in CRS from before to after the operation in the no
CPB group (Table II).
Total phospholipids did not differ between the groups
before the operation. Infants in the no CPB group demonstrat-
ed a postoperative rise in total phospholipids that approached
statistical significance. Total phospholipids declined from
before to after the operation in infants in the CPB group and
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were lower after the operation when compared with the
infants in the no CPB group. Similarly, the phospholipid/pro-
tein ratio exhibited a postoperative decline in the CPB group,
and these infants had a lower postoperative phospholipid/pro-
tein when compared with infants in the no CPB group. The
phospholipid/protein ratio did not change from before to after
the operation in the no CPB group (Table II).
Discussion. Our data demonstrate a postoperative decline
in total phospholipids and phospholipid/protein ratio in
infants undergoing CPB during an operation for congenital
heart disease. This decrease in phospholipids was associated
with a drop in CRS. These data suggest that an increase in
lung phospholipids may be important for overcoming opera-
tive lung injury. However, this response may be attenuated in
infants undergoing bypass during an operation for congenital
heart disease.
CPB has been shown to lead to an increase in pulmonary
edema.2 Lung edema is accompanied by an increase in alve-
olar protein, which is a known inactivator of surfactant.3
Previous investigators have demonstrated an increase in cap-
illary leak and alveolar protein after CPB.4 Along with a
diminution in total phospholipids, the infants in our study
who underwent CPB had a postoperative decline in the phos-
pholipid/protein ratio, which may be indicative of lung injury
and capillary leak. The changes in pulmonary surfactant
demonstrated in the CPB group may be only partially respon-
sible for the operative drop in CRS. Other factors including
atelectasis and changes in pulmonary blood flow could also
have contributed to the postoperative fall in CRS and changes
in surfactant seen in the CPB group.
Our data support the findings of McGowan and col-
leagues,5 who demonstrated an alteration in surfactant com-
position in older infants and children after CPB. Furthermore,
altered capillary permeability associated with CPB may
accelerate pulmonary clearance of secreted surfactant.
Because the postoperative specimens were obtained immedi-
ately after the operative procedure, it is unlikely that the
increase in phospholipids in the no CPB group represented
any increase in de novo surfactant synthesis. We speculate
that the increase in total phospholipids seen in the no CPB
group resulted from ventilation-induced release of stored sur-
factant pools.
In summary, infants undergoing CPB during an operation
for congenital heart disease have diminished total pulmonary
phospholipids in the immediate postoperative period as com-
pared with infants who do not require CPB. This decline in
phospholipids is associated with a decrease in pulmonary
compliance. Infants requiring CPB for surgical repair of con-
genital heart disease may have heightened pulmonary mor-
bidity related to the alteration in surfactant metabolism. This
suggests surfactant replenishment may be beneficial for some
infants who require CPB.
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Table I. Demographic data
CPB (n = 9) No CPB (n=5) P
Age (mo) 2.7 ± 0.8 2.7 ± 1.4 .9
Gestational age (wk) 38.4 ± 0.8 38.8 ± 1.2 .5
Weight (kg) 4.3 ± 0.6 4.0 ± 0.7 .4
Sex (M/F) 4/5 3/2 .6
Table II. Pulmonary function and surfactant data
P (before 
Preoperative Postoperative vs after)
CRS
CPB 0.94 ± 0.12 0.69 ± 0.18 .01
No CPB 0.71 ± 0.39 0.90 ± 0.24 .38
P (CPB vs no CPB) .12 .09
Total phospholipids
CPB 341 ± 231 132 ± 141 .03
No CPB 269 ± 146 648 ± 421 .09
P (CPB vs no CPB) .54 .01
Phospholipid/protein
CPB 0.17 ± 0.11 0.05 ± 0.04 .01
No CPB 0.21 ± 0.17 0.28 ± 0.25 .62
P (CPB vs no CPB) .60 .01
Preoperative and postoperative total phospholipids (micrograms per milli-
liter), phospholipid/protein ratio, and respiratory system CRS (milliliters ·
centimeters H2O–1 · kilogram–1) in the infants in the CPB group and the
infants in the no CPB group.
